Oncology

                   

Hana Biosciences Reports Third Quarter 2008 Results

redorbit.com
13-Nov-2008 1 related
        

SOUTH SAN FRANCISCO, Calif., Nov. 13, 2008 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced its financial results and...

add comment
                   

Singapore Medicine – Singapore Takes Cancer Warfare to New Level with TomoTherapy

pr-usa.net
13-Nov-2008 1 related
        

Singapore’s oncologists are taking cancer warfare to a new level of sophistication with the use of revolutionary but affordable TomoTherapy technology. These days, with advancements in weapons technology, you can lock in a...

add comment

Oncology Phase III Trials

chemeurope.com
13-Nov-2008
        

19 Nov 2008 - 20 Nov 2008 Newark, NJ, United States of America - This interactive and informative course provides a comprehensive overview of the planning and implementation of phase III and phase IV oncology clinical trials....

add comment
                   

Of Mice and Men: Award-Winning Oncologist Leads New Advancement in Personalized Medicine

euroinvestor.co.uk
13-Nov-2008 3 related
        

After hearing the words, "you´ve got cancer," most patients are given a drug or combination of agents according to guidelines or standards of care. These treatments, in the oncologist´s best judgmen.. - Read more

add comment
                   

AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results (PR Newswire)

yahoo.com
13-Nov-2008 4 related
        

Thursday November 13, 7:30 am ET All amounts are in U.S. dollars QUEBEC CITY, Nov. 13 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on endocrinology and...

add comment
                   

IsoRay, Inc. Reports First Quarter Results

redorbit.com
13-Nov-2008 2 related
        

IsoRay Inc. (AMEX:ISR) a medical isotope company focusing on the treatment of prostate and other malignant disease through use of its proprietary radioisotope technology, today announced its financial results for the first...

add comment

Examine the DNA Diagnostics: Technologies and Global Markets

ad-hoc-news.de
13-Nov-2008 10 related
        

Examine the DNA Diagnostics: Technologies and Global MarketsNEW YORKNY-REPORTLINKER NEW YORK--(BUSINESS WIRE)-- INTRODUCTION STUDY GOALS AND OBJECTIVES REASONS FOR DOING THE STUDY SCOPE OF REPORT INTENDED AUDIENCE METHODOLOGY...

add comment

Jefferson Kimmel Cancer Center Network Appoints New Clinical Director

newswise.com
13-Nov-2008
        

Description Leonard Gomella, M.D., was appointed Clinical Director of the Jefferson Kimmel Cancer Center Network. Newswise — The Jefferson Kimmel Cancer Center Network has appointed Leonard Gomella, M.D., F.A.C.S., clinical...

add comment
                   

Molecular Insight Pharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results (Business...

yahoo.com
13-Nov-2008 3 related
        

CAMBRIDGE, Mass.----Molecular Insight Pharmaceuticals, Inc. announced today the financial results for the third quarter and nine months ended September 30, 2008. In a conference call scheduled for 10:00 a.m., Eastern Daylight...

add comment
genengnews.com: Genetic Engineering genengnews.com

AAIPharma Strengthens Global Clinical Development Services Unit With Addition Of Two Executives

pharmiweb.co.uk
12-Nov-2008 7 related
        

AAIPharma, a global provider of drug development services, today announced the appointment of Andreas Dreps, Ph.D., as Senior Vice President, Global Clinical Development Services. In addition, the company also announced that...

add comment